170
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cholesterol values are poor markers of disease risk in a chronic disease population

Pages 545-551 | Published online: 18 Jan 2017
 

Abstract

Aim: Studies have demonstrated reverse epidemiology for various serum lipid values among maintenance hemodialysis patients. The purpose of this study was to investigate the end-stage renal disease population for reverse epidemiology, particularly in the way lipid levels relate to serum albumin concentration. Materials and methods: Lipid profiles and albumin levels were collected from end-stage renal disease patients (n = 117) who were undergoing chronic hemodialysis. Patients were placed in an albumin group (>3.8 g/dl) or a hypoalbumin group (<3.8 g/dl). A stepwise linear-regression model utilized albumin levels in g/dl as the outcome variable and tested the significance of additional covariates. Results: Large LDL-C loaded first (p = 0.0001) followed by LDL-C (p = 0.0001) and LDL-C particle size (p = 0.002). ANOVA revealed significant differences in LDL-C levels (p = 0.001), large LDL-C (p = 0.0001), LDL-C particle size (p = 0.038) and HDL-C (p = 0.045). Conclusion: Our study demonstrated that, when compared with serum albumin levels, a reverse epidemiology effect existed for LDL-C, large LDL-C, LDL-C particle size and HDL-C.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.